| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | RVI BIOTECNOLOGÍA | 39,14% | 87,84% | 77,60% | 300,46% |
| GOLDMAN SACHS EUROPE CORE EQUITY PORTFOLIO I USD CAP | RVI EUROPA | 23,30% | 72,26% | 77,59% | · |
| GSQUARTIX MODIFIED STRATEGY ON THE BLOOMBERG COMMODITY INDEX TOTAL RETURN PORTFOLIO R (GBP HEDGED) | RVI MATERIAS PRIMAS | 44,96% | 54,24% | 77,58% | 76,46% |
| CLEOME INDEX USA EQUITIES R CAP | RVI USA | 19,92% | 67,92% | 77,56% | 275,09% |
| GOLDMAN SACHS JAPAN EQUITY PARTNERS PORTFOLIO OTHER CURRENCY H EUR CAP | RVI JAPÓN | 21,51% | 72,59% | 77,53% | 284,17% |
| JPM GLOBAL RESEARCH ENHANCED INDEX EQUITY I (ACC) USD | RVI GLOBAL | 19,60% | 63,22% | 77,52% | 235,54% |
| ROBECO BP US LARGE CAP EQUITIES D EUR | RVI USA | 23,43% | 54,21% | 77,52% | 185,47% |
| CLEOME INDEX USA EQUITIES R CAP | RVI USA | 19,95% | 67,61% | 77,50% | · |
| BANKINTER FINANZAS GLOBALES, FI C | RVI FINANCIERO | 14,72% | 74,55% | 77,47% | · |
| FAST-EMERGING MARKETS FUND A-PF-ACC-EUR | RVI EMERGENTES | 54,64% | 140,02% | 77,46% | 174,90% |
